Skip to main content

Mesothelioma

Volume 449: debated on Wednesday 19 July 2006

21. To ask the Secretary of State for Health if she will make a statement on the National Institute for Health and Clinical Excellence’s recent decision regarding the provision of Alimta for people with mesothelioma. (85860)

The National Institute for Health and Clinical Excellence (NICE) published its final appraisal determination on pemetrexed disodium (Alimta) for mesothelioma on 26 June. Consultees were given until 10 July to lodge an appeal against NICE’s determination. NICE will not issue final guidance to the NHS until any appeals have been heard.